Cite

HARVARD Citation

    Santoro, N. et al. (2020). Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms. Menopause. 27 (12), p. . [Online]. 
  
Back to record